BBIO earnings
BridgeBio Pharma (BBIO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
BBIO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | -0.42 | -0.54 | 22.54% | $353.17M |
| Q2 2026 | Aug 10, 2026 | -0.78 | -0.58 | -35.52% | $243.68M |
| Q1 2026 | May 7, 2026 | -0.84 | -0.68 | -23.75% | $194.51M |
| Q4 2025 | Feb 24, 2026 | -1.00 | -0.71 | -40.17% | $154.18M |
| Q3 2025 | Oct 29, 2025 | -0.95 | -0.88 | -7.95% | $120.70M |
| Q2 2025 | Aug 5, 2025 | -0.95 | -0.83 | -14.46% | $110.56M |
| Q1 2025 | Apr 29, 2025 | -0.88 | -1.00 | 12.00% | $116.63M |
| Q4 2024 | Feb 20, 2025 | -1.31 | -1.09 | -20.18% | $5.88M |
| Q3 2024 | Nov 12, 2024 | -0.86 | -1.03 | 16.50% | $2.73M |
| Q2 2024 | Jul 31, 2024 | -0.39 | -1.09 | 64.22% | $2.17M |
| Q1 2024 | May 2, 2024 | -0.20 | -0.71 | 71.83% | $211.12M |
| Q4 2023 | Feb 22, 2024 | -0.96 | -0.95 | -1.05% | $1.75M |
| Nov 2, 2023 | -1.08 | -0.86 | -25.58% | – | |
| Aug 3, 2023 | -0.98 | -0.86 | -13.95% | – | |
| May 4, 2023 | -0.92 | -0.84 | -9.52% | – | |
| Feb 23, 2023 | -0.87 | -0.86 | -1.16% | – | |
| Nov 3, 2022 | -0.93 | -1.02 | 8.82% | – | |
| Aug 4, 2022 | -0.07 | -0.56 | 87.43% | – | |
| May 5, 2022 | -1.19 | -1.13 | -5.31% | – | |
| Feb 24, 2022 | -1.01 | -0.83 | -21.69% | – |
- BBIO beat EPS estimates in 10 of its last 30 reports.
Updated 2026-11-02 20:07 UTC